{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:13:01Z","timestamp":1790219581886,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.peptides.2003.07.025","type":"journal-article","created":{"date-parts":[[2003,12,23]],"date-time":"2003-12-23T05:47:38Z","timestamp":1072158458000},"page":"1723-1731","source":"Crossref","is-referenced-by-count":83,"title":["In vitro and in vivo antimicrobial activity of two \u03b1-helical cathelicidin peptides and of their synthetic analogs"],"prefix":"10.1016","volume":"24","author":[{"given":"Monica","family":"Benincasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Skerlavaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2003.07.025_BIB1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0005-2736(95)00087-J","article-title":"Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity","volume":"1237","author":"Ahmad","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.peptides.2003.07.025_BIB2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","article-title":"Toxicity determined in vitro by morphological alterations and neutral red adsorption","volume":"24","author":"Borenfreund","year":"1985","journal-title":"Toxicol Lett."},{"key":"10.1016\/j.peptides.2003.07.025_BIB3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.45.1.331-334.2001","article-title":"The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection","volume":"45","author":"Brogden","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.peptides.2003.07.025_BIB4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0003-2697(89)90597-6","article-title":"Protein estimation by the product of integrated peak area and flow rate","volume":"182","author":"Buck","year":"1989","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.peptides.2003.07.025_BIB5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/1097-0282(2000)55:1<88::AID-BIP80>3.0.CO;2-K","article-title":"Development of protegrins for the treatment and prevention of oral mucositis: structure\u2013activity relationships of synthetic protegrin analogues","volume":"55","author":"Chen","year":"2000","journal-title":"Biopolymers"},{"key":"10.1016\/j.peptides.2003.07.025_BIB6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2174\/1381612023395501","article-title":"Cationic peptides: distribution and mechanisms of resistance","volume":"8","author":"Devine","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.peptides.2003.07.025_BIB7","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1021\/bi00859a010","article-title":"Spectroscopic determination of tryptophan and tyrosine in proteins","volume":"6","author":"Edelhoch","year":"1967","journal-title":"Biochemistry"},{"key":"10.1016\/j.peptides.2003.07.025_BIB8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO;2-9","article-title":"Structural features and biological activities of the cathelicidin-derived antimicrobial peptides","volume":"55","author":"Gennaro","year":"2000","journal-title":"Biopolymers"},{"key":"10.1016\/j.peptides.2003.07.025_BIB9","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1128\/AAC.46.7.2132-2136.2002","article-title":"Potential therapeutic role of cationic peptides in three experimental models of septic shock","volume":"46","author":"Giacometti","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.peptides.2003.07.025_BIB10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/jac\/dkg149","article-title":"In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides","volume":"51","author":"Giacometti","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.peptides.2003.07.025_BIB11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/1568005024605855","article-title":"Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics","volume":"2","author":"Hancock","year":"2002","journal-title":"Curr. Drug Targets Infect. Disord."},{"key":"10.1016\/j.peptides.2003.07.025_BIB12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00062752-200201000-00004","article-title":"Cathelicidins: a family of endogenous antimicrobial peptides","volume":"9","author":"Lehrer","year":"2002","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.peptides.2003.07.025_BIB13","first-page":"96","article-title":"Simplified method of evaluating dose-effect experiments","volume":"113","author":"Litchfield","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2003.07.025_BIB14","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.44.7.1803-1808.2000","article-title":"IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis","volume":"44","author":"Mosca","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.peptides.2003.07.025_BIB15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","article-title":"Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds","volume":"20","author":"Pauwels","year":"1988","journal-title":"J. Virol. Meth."},{"key":"10.1016\/j.peptides.2003.07.025_BIB16","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.peptides.2003.07.025_BIB17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jac\/dkf220","article-title":"Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira","volume":"50","author":"Sambri","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.peptides.2003.07.025_BIB18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/1381612023395367","article-title":"From innate immunity to de-novo designed antimicrobial peptides","volume":"8","author":"Shai","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.peptides.2003.07.025_BIB19","doi-asserted-by":"crossref","first-page":"28375","DOI":"10.1074\/jbc.271.45.28375","article-title":"Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities","volume":"271","author":"Skerlavaj","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2003.07.025_BIB20","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1128\/IAI.58.11.3724-3730.1990","article-title":"Rapid membrane permeabilization and inhibition of vital functions of Gram-negative bacteria by bactenecins","volume":"58","author":"Skerlavaj","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.peptides.2003.07.025_BIB21","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.41.8.1738","article-title":"Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity","volume":"41","author":"Steinberg","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.peptides.2003.07.025_BIB22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(95)01050-O","article-title":"Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain","volume":"374","author":"Zanetti","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.peptides.2003.07.025_BIB23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2174\/1381612023395457","article-title":"Cathelicidin peptides as candidates for a novel class of antimicrobials","volume":"8","author":"Zanetti","year":"2002","journal-title":"Curr. Pharm. Design"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978103003462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978103003462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T06:14:47Z","timestamp":1585376087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978103003462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0196978103003462"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2003.07.025","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}